Literature DB >> 23515544

Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections.

Florence Abravanel1, Sabine Chapuy-Regaud, Sébastien Lhomme, Martine Dubois, Jean-Marie Peron, Laurent Alric, Lionel Rostaing, Nassim Kamar, Jacques Izopet.   

Abstract

We assessed the performance of the Ceeram and Altona assays, the first two commercially available hepatitis E virus (HEV) RNA assays, using serial dilutions of 4 HEV-positive reference samples (genotypes 3a, 3c, 3e, and 3f). Both assays provided good analytical sensitivity and high reproducibility for detecting genotype 3 HEV RNA.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23515544      PMCID： PMC3716096          DOI： 10.1128/JCM.00661-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  27 in total

1.  Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances.

Authors:  Jan Drobeniuc; Jihong Meng; Gábor Reuter; Tracy Greene-Montfort; Natasha Khudyakova; Zoya Dimitrova; Saleem Kamili; Chong-Gee Teo
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

2.  Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections.

Authors:  Florence Legrand-Abravanel; Isabelle Thevenet; Jean-Michel Mansuy; Karine Saune; Françoise Vischi; Jean-Marie Peron; Nassim Kamar; Lionel Rostaing; Jacques Izopet
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

3.  Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.

Authors:  Laurence Ollier; Nathalie Tieulie; Frédérick Sanderson; Philippe Heudier; Valérie Giordanengo; Jean-Gabriel Fuzibet; Elisabeth Nicand
Journal:  Ann Intern Med       Date:  2009-03-17       Impact factor: 25.391

4.  Persistent carriage of hepatitis E virus in patients with HIV infection.

Authors:  Harry R Dalton; Richard P Bendall; Frances E Keane; Richard S Tedder; Samreen Ijaz
Journal:  N Engl J Med       Date:  2009-09-03       Impact factor: 91.245

5.  Hepatitis E in an HIV-infected patient.

Authors:  Philippe Colson; Mamadou Kaba; Jacques Moreau; Philippe Brouqui
Journal:  J Clin Virol       Date:  2009       Impact factor: 3.168

6.  Hepatitis E virus excretion can be prolonged in patients with hematological malignancies.

Authors:  Suzanne Tavitian; Jean-Marie Péron; Anne Huynh; Jean-Michel Mansuy; Loic Ysebaert; Françoise Huguet; Jean-Pierre Vinel; Michel Attal; Jacques Izopet; Christian Récher
Journal:  J Clin Virol       Date:  2010-08-01       Impact factor: 3.168

7.  A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route.

Authors:  Keiji Matsubayashi; Jong-Hon Kang; Hidekatsu Sakata; Kazuaki Takahashi; Motohiro Shindo; Masaru Kato; Shinichiro Sato; Toshiaki Kato; Hiroyuki Nishimori; Kunihiko Tsuji; Hiroyuki Maguchi; Jun-Ichi Yoshida; Hiroshi Maekubo; Shunji Mishiro; Hisami Ikeda
Journal:  Transfusion       Date:  2008-07       Impact factor: 3.157

8.  Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.

Authors:  N Kamar; J-M Mansuy; O Cointault; J Selves; F Abravanel; M Danjoux; P Otal; L Esposito; D Durand; J Izopet; L Rostaing
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

9.  Sources of hepatitis E virus genotype 3 in The Netherlands.

Authors:  Saskia A Rutjes; Willemijn J Lodder; Froukje Lodder-Verschoor; Harold H J L van den Berg; Harry Vennema; Erwin Duizer; Marion Koopmans; Ana Maria de Roda Husman
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

10.  Hepatitis E virus genotype 3 diversity, France.

Authors:  Florence Legrand-Abravanel; Jean-Michel Mansuy; Martine Dubois; Nassim Kamar; Jean-Marie Peron; Lionel Rostaing; Jacques Izopet
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883
View more
  16 in total

1.  Hepatitis E in liver transplant recipients in the Rhône-Alpes region in France.

Authors:  C Buffaz; C Scholtes; A-G Dron; P Chevallier-Queyron; J Ritter; P André; C Ramière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-21       Impact factor: 3.267

2.  Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants.

Authors:  Bo Wang; Dominik Harms; C Patrick Papp; Sandra Niendorf; Sonja Jacobsen; Marc Lütgehetmann; Sven Pischke; Heiner Wedermeyer; Jörg Hofmann; C-Thomas Bock
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

Review 3.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  Bioaccumulation efficiency, tissue distribution, and environmental occurrence of hepatitis E virus in bivalve shellfish from France.

Authors:  Marco Grodzki; Julien Schaeffer; Jean-Côme Piquet; Jean-Claude Le Saux; Julien Chevé; Joanna Ollivier; Jacques Le Pendu; Françoise S Le Guyader
Journal:  Appl Environ Microbiol       Date:  2014-05-02       Impact factor: 4.792

5.  Hepatitis E Virus (HEV) Detection and Quantification by a Real-Time Reverse Transcription-PCR Assay Calibrated to the World Health Organization Standard for HEV RNA.

Authors:  Jeffrey J Germer; Irina Ankoudinova; Yevgeniy S Belousov; Walt Mahoney; Chen Dong; Jihong Meng; Jayawant N Mandrekar; Joseph D Yao
Journal:  J Clin Microbiol       Date:  2017-02-22       Impact factor: 5.948

6.  Hepatitis e virus: current concepts and future perspectives.

Authors:  Harry R Dalton; Suzan D Pas; Richie G Madden; Annemiek A van der Eijk
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

Review 7.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

8.  Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors.

Authors:  T Vollmer; C Knabbe; J Dreier
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

9.  Development and Clinical Validation of a Pangenotypic PCR-Based Assay for the Detection and Quantification of Hepatitis E Virus (Orthohepevirus A Genus).

Authors:  Mario Frías; Pedro López-López; Ismael Zafra; Javier Caballero-Gómez; Isabel Machuca; Ángela Camacho; María A Risalde; Antonio Rivero-Juárez; Antonio Rivero
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

10.  Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.

Authors:  Hélène Bauer; Cécile Luxembourger; Jacques-Eric Gottenberg; Sophie Fournier; Florence Abravanel; Alain Cantagrel; Emmanuel Chatelus; Pascal Claudepierre; Christophe Hudry; Jacques Izopet; Sylvie Fabre; Guillaume Lefevre; Laurent Marguerie; Antoine Martin; Laurent Messer; Anna Molto; Béatrice Pallot-Prades; Yves-Marie Pers; Anne-Marie Roque-Afonso; Christian Roux; Christelle Sordet; Martin Soubrier; Claire Veissier; Daniel Wendling; Jean-Marie Péron; Jean Sibilia
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.